Blood Based Biomarkers
Dr Richard Lobb
Dr Richard Lobb is a translational cancer biologist at the Australian Institute for Bioengineering and Nanotechnology (AIBN), and stream leader in blood-based biomarkers within the centre. Dr Lobb has a strong background in extracellular vesicle (EV) biology, hypoxia research, cancer metastasis and cancer immunology.
His research program at the AIBN develops novel technologies to profile circulating EVs in the blood to determine the composition of the tumour microenvironment and predict disease progression. As the blood-based biomarker stream leader, Dr Lobb’s cross-disciplinary expertise and in-depth knowledge in liquid biopsies will contribute to the aim of translating findings to clinical applications to improve therapeutic monitoring in patients.
The University of Newcastle acknowledges the traditional custodians of the lands within our footprint areas: Awabakal, Darkinjung, Biripai, Worimi, Wonnarua, and Eora Nations. We also pay respect to the wisdom of our Elders past and present.